Publication:
Computational investigation of metal organic frameworks for storage and delivery of anticancer drugs

dc.contributor.authorFındıkçı, İlknur Eruçar
dc.contributor.authorKeskin, S.
dc.contributor.departmentMechanical Engineering
dc.contributor.ozuauthorFINDIKÇI, Ilknur Eruçar
dc.date.accessioned2017-10-27T13:18:51Z
dc.date.available2017-10-27T13:18:51Z
dc.date.issued2017-08-14
dc.descriptionDue to copyright restrictions, the access to the full text of this article is only available via subscription.
dc.description.abstractMetal organic frameworks (MOFs) have been recently used in biomedical applications such as drug storage and drug delivery due to their large surface areas, high pore volumes, and tunable physical and chemical characteristics. In this study, we investigated MOF-74 materials for efficient storage and delivery of two anticancer drug molecules, methotrexate (MTX) and 5-fluorouracil (5-FU). We initially compared the results of our molecular simulations with the available experimental data for the MTX and 5-FU uptakes of various MOFs. Motivated by the good agreement between experiments and simulations, we computed MTX and 5-FU uptakes in 10 different MOF-74 materials having various physical and chemical properties. At low fugacity, MTX adsorption is favored over 5-FU since MTX has stronger interactions with the MOFs whereas at high fugacity, 5-FU adsorption is favored over MTX due to the entropic effects. Our results showed that MOF-74 materials outperform the MTX and 5-FU storage capacities of traditional materials such as polymeric nanoparticles and two dimensional layered nanomaterials. We also examined the diffusion of drug molecules in MOFs considering both single-component and mixture transport for the first time in the literature. Both drug molecules diffuse slowly in MOFs suggesting that MOF-74 materials are strong alternatives to traditional porous materials for delivery of MTX and 5-FU. This computational study will be useful to effectively identify the most promising MOFs for target drug delivery applications prior to experiments. Our results will also guide the experiments for the design and development of MOFs as anticancer drug carrier systems.en_US
dc.description.sponsorshipKoc University Seed Fund Program
dc.identifier.doi10.1039/C7TB01764Ben_US
dc.identifier.endpage7351en_US
dc.identifier.issn2050-7518en_US
dc.identifier.issue35en_US
dc.identifier.scopus2-s2.0-85029512348
dc.identifier.startpage7342en_US
dc.identifier.urihttp://hdl.handle.net/10679/5713
dc.identifier.urihttps://doi.org/10.1039/C7TB01764B
dc.identifier.volume5en_US
dc.identifier.wos000411330100012
dc.language.isoengen_US
dc.peerreviewedyesen_US
dc.publicationstatusPublisheden_US
dc.publisherRoyal Society of Chemistryen_US
dc.relation.ispartofJournal of Materials Chemistry B
dc.relation.publicationcategoryInternational Refereed Journal
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subject.keywordsMethotrexate
dc.subject.keywordsCarriers
dc.subject.keywordsRelease
dc.subject.keywordsSimulations
dc.subject.keywordsCombination
dc.subject.keywordsDoxorubicin
dc.subject.keywordsPlga
dc.titleComputational investigation of metal organic frameworks for storage and delivery of anticancer drugsen_US
dc.typeArticleen_US
dspace.entity.typePublication
relation.isOrgUnitOfPublicationdaa77406-1417-4308-b110-2625bf3b3dd7
relation.isOrgUnitOfPublication.latestForDiscoverydaa77406-1417-4308-b110-2625bf3b3dd7

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.45 KB
Format:
Item-specific license agreed upon to submission
Description: